Acorda Therapeutics' President and CEO Ron Cohen, MD Named Ernst ...
Business Wire (press release) - San Francisco,CA,USA
Acorda is conducting Phase 3 trials of Fampridine-SR to evaluate its safety and efficacy in improving walking ability in people with MS. ...
See all stories on this topic